 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Top Clinical Chemistry Researcher Warns of Faulty Antibodies Infiltrating US, European Markets
November 09, 2012
Top Clinical Chemistry Researcher Warns of Faulty Antibodies Infiltrating US, European Markets
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Bruker, GBC Proteomics Centre Protein Assay Deal Points to New Clinical Markets for MALDI Biotyper
April 19, 2013 / ProteoMonitor - Driven by Potential Cost Savings, Convenience, Proteomics Explores Dried Blood Spot Analysis
March 15, 2013 / ProteoMonitor - New Vendor Collaborations, Publications, Products Suggest Clinical Mass Spec 'Ready for Prime Time'
February 15, 2013 / ProteoMonitor - CPTAC, Seoul National University to Test Proteomic Workflows Including MRM-MS in Clinical Setting
February 8, 2013 / ProteoMonitor